Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Deal Watch: Merck Hopes Moderna's Personalized Vaccines Can Increase Keytruda Patient Base

Executive Summary

Novartis and Xencor sign wide-ranging immuno-oncology collaboration targeting multiple CD pathways. Teva signs divestment agreements with five firms during June to meet FTC requirements for its acquisition of Allergan's generics business.

Advertisement

Related Content

Deal Watch: Bristol Leaves Neuropathic Pain Candidate To Lexicon
Regeneron’s Fasinumab Brings Second Clinical Hold For Anti-NGF Class
Sanofi Looks To Climb Consumer Ladder In Boehringer Business Swap
Infinity Gets More Than A Cash Boost With AbbVie Tie-Up

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS057748

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel